Filter
396
Text search:
XDR-TB
Featured
Recommendations
52
New Publications
108
Language
Document type
No document type
309
Studies & Reports
25
Guidelines
25
Situation Updates
12
Manuals
8
Fact sheets
6
Training Material
5
Strategic & Response Plan
4
Resource Platforms
1
Infographics
1
Countries / Regions
Western and Central Europe
45
Eastern Europe
31
South Africa
15
India
14
Namibia
9
Kenya
8
Tanzania
8
Bangladesh
8
Uganda
6
Nepal
6
Germany
6
Ukraine
6
Myanmar / Burma
6
Russia
6
Ethiopia
5
Zambia
4
Botswana
4
Latin America and the Carribbean
4
Senegal
3
Ghana
3
Mozambique
3
Colombia
3
Asia
3
Armenia
3
Global
3
Sierra Leone
2
Philippines
2
Malawi
2
Eswatini/ Swaziland
2
Lesotho
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Paraguay
2
Tajikistan
2
Georgia
2
Vietnam
2
Cambodia
1
Gambia
1
Rwanda
1
Indonesia
1
Peru
1
Madagascar
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Africa
1
Albania
1
Timor Leste/ East Timor
1
Estonia
1
Romania
1
Moldova
1
Kazakhstan
1
Turkmenistan
1
Azerbaijan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
138
Clinical Guidelines
41
Public Health
10
Capacity Building
7
Key Resources
4
Pharmacy & Technologies
4
Women & Child Health
1
Toolboxes
TB
253
HIV
28
AMR
18
Polio
9
Refugee
6
Ebola
4
Pharmacy
4
Rapid Response
2
Caregiver
2
NTDs
2
Disability
1
Specific Hazards
1
COVID-19
1
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-
...
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD ...
The term "Programmatic Management of Drug Resistant TB" (PMD ...
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Mozambique.
BMC Infectious Diseases (2016) 16:423 DO
...
Revised National Tuberculosis Control Programme
Antimicrobial Resistance and Infection Control 2014,3 :31
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la
...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s
...
Tuberculosis MDR-TB & XDR-TB The 2008 Report
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- an
...